A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

NCT03972111 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped commitment fulfilled

Conditions

Smallpox

Interventions

DRUG: TPOXX 200Mg Capsule

Sponsor

SIGA Technologies

Collaborators

[object Object]